Drug Testing Locations - Lancaster, PA

Drug Testing in Lancaster, PA

Lancaster, Pennsylvania Statistics

Lancaster, in Lancaster County, PA, reported a significant increase in opioid-related overdose deaths between 2019 and 2021.

In 2020, Lancaster city saw a 25% increase in drug-related emergency room visits compared to the previous year.

Lancaster County, PA ranked among the top counties in the state for methamphetamine-related arrests in 2021.

The Lancaster County Coroner's Office reported 130 drug overdose deaths in 2022.

A 2021 survey indicated 15% of Lancaster city high school students admitted to non-prescribed use of prescription drugs.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Lancaster, PA & Drug Testing Policies

Employers in Lancaster, PA, have increasingly adopted stringent drug testing policies to ensure a safe workplace. Many companies require pre-employment screening and regular random testing to deter drug abuse among employees. The city's large healthcare and manufacturing sectors are particularly vigilant due to safety concerns.

Local policies align with the U.S. Department of Labor's guidelines, which offer resources for implementing workplace drug testing. Employers can contact the Department of Labor's website for comprehensive information and support.

Government Efforts with Drug Problems in Lancaster, PA

The government of Lancaster, PA, along with Lancaster County, has implemented several initiatives to combat drug problems. The Lancaster County Drug Task Force actively collaborates with local law enforcement to monitor and reduce drug trafficking. For more information on their efforts, visit the Lancaster County Police Department website.

The state of Pennsylvania has also supported local initiatives by funding treatment programs and public awareness campaigns. Pennsylvania's Department of Drug and Alcohol Programs provides resources and guidance on statewide efforts. Visit their official website for more details.

Local Drug Busts & News in Lancaster, PA

The quiet city of Lancaster, PA, known for its rich history and vibrant community, has recently seen a rise in drug-related events. Local authorities have ramped up efforts to tackle the issue, leading to significant drug busts. These operations have spotlighted the presence of illegal substances and emphasized the community's commitment to eradicating drug-related activities.

In an effort to combat the drug crisis, Lancaster police have increased patrols in known hotspots, leading to several successful raids. These operations have led to multiple arrests and the seizure of substantial quantities of narcotics. The commitment of law enforcement is evident in their collaboration with community leaders to address the root causes of drug abuse.

Community outreach programs have begun to play a crucial role in Lancaster’s ongoing battle against drug issues. Local organizations have worked tirelessly to provide support and resources to individuals struggling with addiction. These initiatives aim to restore safety in the community and offer a second chance to those seeking recovery.

The recent drug busts in Lancaster have highlighted the need for continued vigilance and cooperation between law enforcement and residents. The city is taking a proactive stance against the epidemic by increasing awareness and strengthening preventative measures. This collaboration is essential in fostering a safer environment for all residents.

The impact of drug-related activities in Lancaster extends beyond law enforcement, affecting families and local businesses. As the community rallies together, there is a shared focus on educational programs to deter youth from drug involvement. These efforts are crucial in building resilience and ensuring the well-being of future generations in Lancaster.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Lancaster, PA. Trusted by employers nationwide for accurate results and exceptional service.

Pennsylvania DOT/Non DOT Physicals

Pennsylvania Vision Tests

Pennsylvania Audiograms

Pennsylvania Respirator Fit Tests

Pennsylvania Lift Tests

Pennsylvania Background Checks

Clinical Testing Services

TB Testing in PA

Diabetes Testing in PA

Infectious Disease Testing in PA

Sickle Cell Anemia Testing in PA

Women/Men's Health Testing in PA

Resources & Citations

U.S. Attorney's Office Middle District of Pennsylvania

PA Department of Drug and Alcohol Programs

Lancaster County Drug & Alcohol Commission

Caron Treatment Centers

Gate House Behavioral Health Services

Psychiatry Management Company

White Deer Run Treatment Network

Gateway Rehab

Drug Testing Near Lancaster, PA

Landisville, PA

Bird in Hand, PA

Bird-in-Hand, PA

Smoketown, PA

Witmer, PA

Petersburg, PA

East Petersburg, PA

Lampeter, PA

Willow Street, PA

Millersville, PA

Frequently Asked Questions

Customer Reviews